
    
      Vimentin/Pan CK staining will be performed on tissues of patient who visited Seoul National
      University Hospital and were diagnosed with triple negative breast cancer and decided to
      perform neoadjuvant chemotherapy under clinical judgement.

      Histologically determined to be a metaplastic breast cancer or tested positive for
      vimentin/Pan CK patients decides as the metaplastic breast cancer. They evaluate the response
      rate of the neoadjuvant chemotherapy.

      Patients with vimentin/Pan CK negative are diagnosed with non-metaplastic breast cancer and
      this group also confirms the response rate of neoadjuvant chemotherapy.

      The group of metaplastic breast cancer will enroll 50 people, and the group of
      non-metaplastic breast cancer will enroll 100 people.
    
  